Patients with type 2 diabetes who also meet a Tier 2 or Tier 3 condition (such as HFpEF, CKD, prior heart attack, or stroke) and the corresponding BMI threshold may qualify under the Bridge for chronic weight management
Semaglutide peptide is a derivative of the naturally occurring GLP-1 used to treat type 2 diabetes
Lenzi, A., Sgr, P., Salacone, P., Paoli, D., Gilio, B., Lombardo, F.,
Semaglutide mimics the action of the hormone GLP-1
Key takeaways: Tirzepatide is a drug that reduces appetite, slows digestion, and regulates blood sugar by mimicking two hormones (GLP-1 and GIP)
However, keeping track of your symptoms can help you and your healthcare provider determine whether your response requires further investigation